Aryloxy amine compounds and their use as sodium channel modulators

Details for Australian Patent Application No. 2008318293 (hide)

Owner Howard Florey Institute

Inventors Jarrott, Bevyn

Agent Davies Collison Cave

Pub. Number AU-A-2008318293

PCT Pub. Number WO2009/055869

Priority 60/984,681 01.11.07 US

Filing date 31 October 2008

Wipo publication date 7 May 2009

International Classifications

C07C 217/18 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

C07C 217/16 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 217/20 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/055869 Priority application(s): WO2009/055869

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008318294-Transmission

2008318291-Treatment of metabolic disease